Breaking down the barrier: The effects of HIV-1 on the blood-brain barrier

Brain Research

Volumn 1399, Issue , 2011, Pages 96-115

  Strazza, Marianne ^a   Pirrone, Vanessa ^a   Wigdahl, Brian ^a   Nonnemacher, Michael R ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Blood brain barrier; Drugs of abuse; gp120; HIV; Nef; Tat

Indexed keywords

CHEMOKINE; CYTOKINE; GLYCOPROTEIN GP 120; NEF PROTEIN; TRANSACTIVATOR PROTEIN;

AGING; ALCOHOL ABUSE; ASTROCYTE; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; COGNITIVE DEFECT; DRUG ABUSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE DEFICIENCY; INFLAMMATION; MACROPHAGE; MICROGLIA; MONOCYTE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; REVIEW; VIRUS CELL INTERACTION;

ANIMALS; BLOOD-BRAIN BARRIER; HIV; HIV INFECTIONS; HUMANS; MACROPHAGES; MODELS, BIOLOGICAL;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79958820845     PISSN: 00068993     EISSN: 00068993     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.05.015     Document Type: Review

References (156)

1. Alvarez, J.I., Cayrol, R., Prat, A., 2011. Disruption of central nervous system barriers in multiple sclerosis. Biochim. Biophys. Acta. 1812, 252-264.
2. Appay, V., Sauce, D., 2008. Immune activation and inflammation in HIV-1 infection: causes and consequences. J. Pathol. 214, 231-241. (Pubitemid 351160160)
3. Banerjee, A., Zhang, X., Manda, K.R., Banks, W.A., Ercal, N., 2010. HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide. Free Radic. Biol. Med. 48, 1388-1398.
4. Banks, W.A., Kastin, A.J., Akerstrom, V., 1997. HIV-1 protein gp120 crosses the blood-brain barrier: role of adsorptive endocytosis. Life Sci. 61, PL119-PL125.
5. Banks, W.A., Akerstrom, V., Kastin, A.J., 1998. Adsorptive endocytosis mediates the passage of HIV-1 across the blood-brain barrier: evidence for a post-internalization coreceptor. J. Cell Sci. 111 (Pt 4), 533-540. (Pubitemid 28098401)
6. Banks, W.A., Robinson, S.M., Nath, A., 2005. Permeability of the blood-brain barrier to HIV-1 Tat. Exp. Neurol. 193, 218-227.
7. Barillari, G., Sgadari, C., Fiorelli, V., Samaniego, F., Colombini, S., Manzari, V., Modesti, A., Nair, B.C., Cafaro, A., Sturzl, M., Ensoli, B., 1999. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood 94, 663-672. (Pubitemid 29323880)
8. Bo, L., Peterson, J.W., Mork, S., Hoffman, P.A., Gallatin, W.M., Ransohoff, R.M., Trapp, B.D., 1996. Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the beta 2 integrin LFA-1 in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55, 1060-1072.
9. Bonkowski, D., Katyshev, V., Balabanov, R.D., Borisov, A., Dore-Duffy, P., 2011. The CNS microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival. Fluids Barriers CNS. 8, 8.
10. Buonaguro, L., Barillari, G., Chang, H.K., Bohan, C.A., Kao, V., Morgan, R., Gallo, R.C., Ensoli, B., 1992. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J. Virol. 66, 7159-7167.
11. Burdo, T.H., Soulas, C., Orzechowski, K., Button, J., Krishnan, A., Sugimoto, C., Alvarez, X., Kuroda, M.J., Williams, K.C., 2010. Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog. 6, e1000842.
12. Butt, A.M., Jones, H.C., Abbott, N.J., 1990. Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J. Physiol. 429, 47-62. (Pubitemid 20327537)
13. Cao, W., Jamieson, B.D., Hultin, L.E., Hultin, P.M., Effros, R.B., Detels, R., 2009. Premature aging of T cells is associated with faster HIV-1 disease progression. J. Acquir. Immune Defic. Syndr. 50, 137-147.
14. Carman, C.V., Springer, T.A., 2003. Integrin avidity regulation: are changes in affinity and conformation underemphasized? Curr. Opin. Cell Biol. 15, 547-556.
15. Carman, C.V., Springer, T.A., 2004. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J. Cell Biol. 167, 377-388. (Pubitemid 39435079)
16. Carman, C.V., 2009. Mechanisms for transcellular diapedesis: probing and pathfinding by 'invadosome-like protrusions'. J. Cell Sci. 122, 3025-3035.
17. Carrithers, M.D., Visintin, I., Kang, S.J., Janeway Jr., C.A., 2000. Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain 123 (Pt 6), 1092-1101.
18. Carter, C.C., Onafuwa-Nuga, A., McNamara, L.A., J.t., Riddell, D., Bixby, D., Savona, K.L., Collins, 2010. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat. Med. 16, 446-451.
19. Cavanagh, L.L., Bonasio, R., Mazo, I.B., Halin, C., Cheng, G., van der Velden, A.W., Cariappa, A., Chase, C., Russell, P., Starnbach, M.N., Koni, P.A., Pillai, S., Weninger,W., von Andrian, U.H., 2005. Activation of bone marrow-residentmemory T cells by circulating, antigen-bearing dendritic cells. Nat. Immunol. 6, 1029-1037.
20. Cayrol, R., Wosik, K., Berard, J.L., Dodelet-Devillers, A., Ifergan, I., Kebir, H., Haqqani, A.S., Kreymborg, K., Krug, S., Moumdjian, R., Bouthillier, A., Becher, B., Arbour, N., David, S., Stanimirovic, D., Prat, A., 2008. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 9, 137-145.
21. Chene, G., Binquet, C., Moreau, J.F., Neau, D., Pellegrin, I., Malvy, D., Ceccaldi, J., Lacoste, D., Dabis, F., 1998. Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. AIDS 12, 2313-2320. (Pubitemid 28526411)
22. Churcher,M.J., Lamont, C., Hamy, F., Dingwall, C., Green, S.M., Lowe, A.D., Butler, J.G., Gait, M.J., Karn, J., 1993. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stemand amino acid residues flanking the basic region. J. Mol. Biol. 230, 90-110.
23. Cioni, C., Annunziata, P., 2002. Circulating gp120 alters the blood-brain barrier permeability in HIV-1 gp120 transgenic mice. Neurosci. Lett. 330, 299-301.
24. Connor, M.D., Lammie, G.A., Bell, J.E., Warlow, C.P., Simmonds, P., Brettle, R.D., 2000. Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort. Stroke 31, 2117-2126.
25. Couty, J.P., Rampon, C., Leveque, M., Laran-Chich, M.P., Bourdoulous, S., Greenwood, J., Couraud, P.O., 2007. PECAM-1 engagement counteracts ICAM-1-induced signaling in brain vascular endothelial cells. J. Neurochem. 103, 793-801. (Pubitemid 47498026)
26. Cysique, L.A., Vaida, F., Letendre, S., Gibson, S., Cherner, M., Woods, S.P., McCutchan, J.A., Heaton, R.K., Ellis, R.J., 2009. Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 73, 342-348.
27. Dallasta, L.M., Pisarov, L.A., Esplen, J.E., Werley, J.V., Moses, A.V., Nelson, J.A., Achim, C.L., 1999. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155, 1915-1927.
28. Dhillon, N.K., Peng, F., Bokhari, S., Callen, S., Shin, S.H., Zhu, X., Kim, K.J., Buch, S.J., 2008. Cocaine-mediated alteration in tight junction protein expression and modulation of CCL2/CCR2 axis across the blood-brain barrier: implications for HIV-dementia. J. Neuroimmune Pharmacol. 3, 52-56.
29. Dore-Duffy, P., Peterson, M., Catalanotto, F., Marlow, S., Ho, S.Y., Ostrom, M., Weinstein, A., 1990. Zinc profiles in rheumatoid arthritis. Clin. Exp. Rheumatol. 8, 541-546.
30. Dorfel, M.J., Westphal, J.K., Huber, O., 2009. Differential phosphorylation of occludin and tricellulin by CK2 and CK1. Ann. N. Y. Acad. Sci. 1165, 69-73.
31. Elali, A., Hermann, D.M., 2011. ATP-binding cassette transporters and their roles in protecting the brain. Neuroscientist.
32. Ellery, P.J., Tippett, E., Chiu, Y.L., Paukovics, G., Cameron, P.U., Solomon, A., Lewin, S.R., Gorry, P.R., Jaworowski, A., Greene, W. C., Sonza, S., Crowe, S.M., 2007. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 178, 6581-6589. (Pubitemid 46717442)
33. Engelhardt, B., Wolburg, H., 2004. Mini-review: transendothelial migration of leukocytes: through the front door or around the side of the house? Eur. J. Immunol. 34, 2955-2963. (Pubitemid 39549374)
34. Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R.A., Wingfield, P., Gallo, R.C., 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67, 277-287. (Pubitemid 23002988)
35. Ernst, T., Chang, L., 2004. Effect of aging on brain metabolism in antiretroviral-naive HIV patients. AIDS 18 (Suppl 1), S61-S67. (Pubitemid 38365907)
36. Eugenin, E.A., Berman, J.W., 2007. Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes. J. Neurosci. 27, 12844-12850. (Pubitemid 350159592)
37. Farkas, E., Sule, Z., Toth-Szuki, V., Matyas, A., Antal, P., Farkas, I.G., Mihaly, A., Bari, F., 2006. Tumor necrosis factor-alpha increases cerebral blood flow and ultrastructural capillary damage through the release of nitric oxide in the rat brain. Microvasc. Res. 72, 113-119.
38. Fiala, M., Gan, X.H., Zhang, L., House, S.D., Newton, T., Graves, M. C., Shapshak, P., Stins, M., Kim, K.S., Witte, M., Chang, S.L., 1998. Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? Adv. Exp. Med. Biol. 437, 199-205.
39. Fiala, M., Eshleman, A.J., Cashman, J., Lin, J., Lossinsky, A.S., Suarez, V., Yang, W., Zhang, J., Popik, W., Singer, E., Chiappelli, F., Carro, E., Weinand, M., Witte, M., Arthos, J., 2005. Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells. J. Neurovirol. 11, 281-291. (Pubitemid 41122416)
40. + T cell depletion in mice doubly transgenic for HIV gp120 and human CD4. Eur. J. Immunol. 27, 1319-1324.
41. Fiorelli, V., Barillari, G., Toschi, E., Sgadari, C., Monini, P., Sturzl, M., Ensoli, B., 1999. IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis. J. Immunol. 162, 1165-1170. (Pubitemid 29035449)
42. + peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J. Neurovirol. 7, 528-541.
43. Fischer-Smith, T., Croul, S., Adeniyi, A., Rybicka, K., Morgello, S., Khalili, K., Rappaport, J., 2004. Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am. J. Pathol. 164, 2089-2099.
44. Floris, S., Ruuls, S.R., Wierinckx, A., van der Pol, S.M., Dopp, E., van der Meide, P.H., Dijkstra, C.D., De Vries, H.E., 2002. Interferon-beta directly influences monocyte infiltration into the central nervous system. J. Neuroimmunol. 127, 69-79. (Pubitemid 34603576)
45. Folks, T.M., Kessler, S.W., Orenstein, J.M., Justement, J.S., Jaffe, E.S., Fauci, A.S., 1988. Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science 242, 919-922. (Pubitemid 19015253)
46. Gan, X., Zhang, L., Newton, T., Chang, S.L., Ling, W., Kermani, V., Berger, O., Graves, M.C., Fiala, M., 1998. Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects. Clin. Immunol. Immunopathol. 89, 181-190.
47. Gan, X., Zhang, L., Berger, O., Stins, M.F., Way, D., Taub, D.D., Chang, S.L., Kim, K.S., House, S.D., Weinand, M., Witte, M., Graves, M.C., Fiala, M., 1999. Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin. Immunol. 91, 68-76.
48. Gandhi, N., Saiyed, Z.M., Napuri, J., Samikkannu, T., Reddy, P.V., Agudelo, M., Khatavkar, P., Saxena, S.K., Nair, M.P., 2010. Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder. J. Neurovirol. 16, 294-305.
49. Gandhi, R.T., Spritzler, J., Chan, E., Asmuth, D.M., Rodriguez, B., Merigan, T.C., Hirsch, M.S., Shafer, R.W., Robbins, G.K., Pollard, R.B., 2006. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J. Acquir. Immune Defic. Syndr. 42, 426-434.
50. Gendelman, H.E., 2005. The Neurology of AIDS. Oxford University Press, Oxford; New York.
51. Gendelman, H.E., Ding, S., Gong, N., Liu, J., Ramirez, S.H., Persidsky, Y., Mosley, R.L., Wang, T., Volsky, D.J., Xiong, H., 2009. Monocyte chemotactic protein-1 regulates voltage-gated K+ channels and macrophage transmigration. J. Neuroimmune Pharmacol. 4, 47-59.
52. Glass, J.D., Fedor, H., Wesselingh, S.L., McArthur, J.C., 1995. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38, 755-762.
53. Graesser, D., Solowiej, A., Bruckner, M., Osterweil, E., Juedes, A., Davis, S., Ruddle, N.H., Engelhardt, B., Madri, J.A., 2002. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J. Clin. Invest. 109, 383-392.
54. Graham, N.M., Zeger, S.L., Park, L.P., Vermund, S.H., Detels, R., Rinaldo, C.R., Phair, J.P., 1992. The effects on survival of early treatment of human immunodeficiency virus infection. N. Engl. J. Med. 326, 1037-1042.
55. Greenwood, J., Heasman, S.J., Alvarez, J.I., Prat, A., Lyck, R., Engelhardt, B., 2011. Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain. Neuropathol. Appl. Neurobiol. 37, 24-39.
56. Hamm, S., Dehouck, B., Kraus, J., Wolburg-Buchholz, K., Wolburg, H., Risau, W., Cecchelli, R., Engelhardt, B., Dehouck, M.P., 2004. Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts. Cell Tissue Res. 315, 157-166. (Pubitemid 38657422)
57. Hammer, S.M., Squires, K.E., Hughes, M.D., Grimes, J.M., Demeter, L.M., Currier, J.S., Eron Jr., J.J., Feinberg, J.E., Balfour Jr., H.H., Deyton, L.R., Chodakewitz, J.A., Fischl, M.A., 1997. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N. Engl. J. Med 337, 725-733.
58. Haorah, J., Knipe, B., Leibhart, J., Ghorpade, A., Persidsky, Y., 2005. Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction. J. Leukoc. Biol. 78, 1223-1232.
59. Hasegawa, A., Liu, H., Ling, B., Borda, J.T., Alvarez, X., Sugimoto, C., Vinet-Oliphant, H., Kim, W.K., Williams, K.C., Ribeiro, R.M., Lackner, A.A., Veazey, R.S., Kuroda, M.J., 2009. The level of monocyte turnover predicts disease progression in the macaque model of AIDS. Blood 114, 2917-2925.
60. Herve, F., Ghinea, N., Scherrmann, J.M., 2008. CNS delivery via adsorptive transcytosis. AAPS J. 10, 455-472.
61. Holman, D.W., Klein, R.S., Ransohoff, R.M., 2011. The blood-brain barrier, chemokines and multiple sclerosis. Biochim. Biophys. Acta. 1812, 220-230.
62. Hunt, P.W., Deeks, S.G., Rodriguez, B., Valdez, H., Shade, S.B., Abrams, D.I., Kitahata, M.M., Krone, M., Neilands, T.B., Brand, R. J., Lederman, M.M., Martin, J.N., 2003. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS 17, 1907-1915.
63. Ivey, N.S., MacLean, A.G., Lackner, A.A., 2009. Acquired immunodeficiency syndrome and the blood-brain barrier. J. Neurovirol. 15, 111-122.
64. Jeang, K.T., Xiao, H., Rich, E.A., 1999. Multifaceted activities of the HIV-1 transactivator of transcription. Tat. J. Biol. Chem. 274, 28837-28840.
65. Jernigan, T.L., Gamst, A.C., Archibald, S.L., Fennema-Notestine, C., Mindt, M.R., Marcotte, T.D., Heaton, R.K., Ellis, R.J., Grant, I., 2005. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am. J. Psychiatry 162, 1461-1472. (Pubitemid 41105560)
66. Joint United Nations Programme on HIV/AIDS (UNAIDS/World Health Organization), 2009. AIDS epidemic update-November 2009.
67. Ju, S.M., Song, H.Y., Lee, J.A., Lee, S.J., Choi, S.Y., Park, J., 2009. Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes. Exp. Mol. Med. 41, 86-93.
68. Kanmogne, G.D., Primeaux, C., Grammas, P., 2005. HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J. Neuropathol. Exp. Neurol. 64, 498-505.
69. Kanmogne, G.D., Schall, K., Leibhart, J., Knipe, B., Gendelman, H.E., Persidsky, Y., 2007. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab. 27, 123-134. (Pubitemid 46006590)
70. Kinoh, H., Sato, H., Tsunezuka,Y., Takino, T., Kawashima, A.,Okada, Y., Seiki, M., 1996. MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J. Cell Sci. 109 (Pt 5), 953-959. (Pubitemid 26168248)
71. Kirchhoff, F., Schindler, M., Specht, A., Arhel, N., Munch, J., 2008. Role of Nef in primate lentiviral immunopathogenesis. Cell Mol. Life Sci. 65, 2621-2636.
72. Kirk, J.B., Goetz, M.B., 2009. Human immunodeficiency virus in an aging population, a complication of success. J. Am. Geriatr. Soc. 57, 2129-2138.
73. Kiyatkin, E.A., Sharma, H.S., 2009. Acute methamphetamine intoxication brain hyperthermia, blood-brain barrier, brain edema, and morphological cell abnormalities. Int. Rev. Neurobiol. 88, 65-100.
74. Klein, R.S., Williams, K.C., Alvarez-Hernandez, X., Westmoreland, S., Force, T., Lackner, A.A., Luster, A.D., 1999. Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS. J. Immunol. 163, 1636-1646. (Pubitemid 29352789)
75. Kohleisen, B., Shumay, E., Sutter, G., Foerster, R., Brack-Werner, R., Nuesse, M., Erfle, V., 1999. Stable expression of HIV-1 Nef induces changes in growth properties and activation state of human astrocytes. AIDS 13, 2331-2341.
76. Krumbholz, M., Theil, D., Cepok, S., Hemmer, B., Kivisakk, P., Ransohoff, R.M., Hofbauer, M., Farina, C., Derfuss, T., Hartle, C., Newcombe, J., Hohlfeld, R., Meinl, E., 2006. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 129, 200-211. (Pubitemid 43063771)
77. Lai, C.H., Kuo, K.H., 2005. The critical component to establish in vitro BBB model: pericyte. Brain Res. Brain Res. Rev. 50, 258-265.
78. Lal-Nag, M., Morin, P.J., 2009. The claudins. Genome Biol. 10, 235.
79. Larussa, D., Lorenzini, P., Cingolani, A., Bossolasco, S., Grisetti, S., Bongiovanni, M., Moretti, F., Uccella, I., Zannoni, P., Foresti, S., Mazzarello, G., Arcidiacono, M.I., Pedale, R., Ammassari, A., Tozzi, V., Perno, C.F., Monforte, A.D., Cinque, P., Antinori, A., 2006. Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients. AIDS Res. Hum. Retroviruses. 22, 386-392.
80. Lehmann, M.H., Masanetz, S., Kramer, S., Erfle, V., 2006. HIV-1 Nef upregulates CCL2/MCP-1 expression in astrocytes in a myristoylation- and calmodulin-dependent manner. J. Cell Sci. 119, 4520-4530. (Pubitemid 44830651)
81. Ley, K., Laudanna, C., Cybulsky, M.I., Nourshargh, S., 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689.
82. Li, J.C., Lee, D.C., Cheung, B.K., Lau, A.S., 2005. Mechanisms for HIV Tat upregulation of IL-10 and other cytokine expression: kinase signaling and PKR-mediated immune response. FEBS Lett. 579, 3055-3062. (Pubitemid 40797834)
83. Li, T.S., Tubiana, R., Katlama, C., Calvez, V., Ait Mohand, H., Autran, B., 1998. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 351, 1682-1686. (Pubitemid 28254528)
84. Lopez-Huertas, M.R., Callejas, S., Abia, D., Mateos, E., Dopazo, A., Alcami, J., Coiras, M., 2010. Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon. Nucleic Acids Res. 38, 3287-3307.
85. Lossinsky, A.S., Shivers, R.R., 2004. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review Histol Histopathol. 19, 535-564. (Pubitemid 38450634)
86. Lv, S., Song, H.L., Zhou, Y., Li, L.X., Cui, W., Wang, W., Liu, P., 2010. Tumour necrosis factor-alpha affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure. Liver Int. 30, 1198-1210.
87. MacLean, A.G., Rasmussen, T.A., Bieniemy, D., Lackner, A.A., 2004. Activation of the blood-brain barrier by SIV (simian immunodeficiency virus) requires cell-associated virus and is not restricted to endothelial cell activation. Biochem. Soc. Trans. 32, 750-752.
88. Magnuson, D.S., Knudsen, B.E., Geiger, J.D., Brownstone, R.M., Nath, A., 1995. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37, 373-380.
89. Mahajan, S.D., Aalinkeel, R., Sykes, D.E., Reynolds, J.L., Bindukumar, B., Fernandez, S.F., Chawda, R., Shanahan, T.C., Schwartz, S.A., 2008. Tight junction regulation by morphine and HIV-1 tat modulates blood-brain barrier permeability. J. Clin. Immunol. 28, 528-541.
90. Mahlknecht, U., Dichamp, I., Varin, A., Van Lint, C., Herbein, G., 2008. NF-kappaB-dependent control of HIV-1 transcription by the second coding exon of Tat in T cells. J. Leukoc. Biol. 83, 718-727.
91. Masliah, E., Ge, N., Mucke, L., 1996. Pathogenesis of HIV-1 associated neurodegeneration. Crit. Rev. Neurobiol. 10, 57-67.
92. Matsubara, M., Jing, T., Kawamura, K., Shimojo, N., Titani, K., Hashimoto, K., Hayashi, N., 2005. Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. Protein Sci. 14, 494-503. (Pubitemid 40194602)
93. McArthur, J.C., 2004. HIV dementia: an evolving disease. J. Neuroimmunol. 157, 3-10. (Pubitemid 39576633)
94. McCandless, E.E., Wang, Q., Woerner, B.M., Harper, J.M., Klein, R.S., 2006. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J. Immunol. 177, 8053-8064. (Pubitemid 44846323)
95. Miller, V., Staszewski, S., Nisius, G., Lepri, A.C., Sabin, C., Phillips, A.N., 1999. Risk of new AIDS diseases in people on triple therapy. Lancet 353, 463. (Pubitemid 29067340)
96. Muller, W.A., Weigl, S.A., Deng, X., Phillips, D.M., 1993. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178, 449-460.
97. Myers, G., Korber, B.T., Foley, B.T., Jeang, K.-T., Mellors, J.W., Wain-Hobson, S., 1996. Human retroviruses and AIDS: a compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM. III-11-III-26.
98. Nair, M.P., Schwartz, S.A., Mahajan, S.D., Tsiao, C., Chawda, R.P., Whitney, R., Don Sykes, B.B., Hewitt, R., 2004. Drug abuse and neuropathogenesis of HIV infection: role of DC-SIGN and IDO. J. Neuroimmunol. 157, 56-60. (Pubitemid 39576637)
99. Nakagawa, S., Toborek, M., 2011. Human immunodeficiency virus type I (HIV-1) infects human brain pericytes in vitro. Journal of Neuroimmune Pharmacology 6, S38.
100. Nakamuta, S., Endo, H., Higashi, Y., Kousaka, A., Yamada, H., Yano, M., Kido, H., 2008. Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells. J. Neurovirol. 14, 186-195. (Pubitemid 351895540)
101. Nath, A., Schiess, N., Venkatesan, A., Rumbaugh, J., Sacktor, N., McArthur, J., 2008. Evolution of HIV dementia with HIV infection. Int. Rev. Psychiatry 20, 25-31.
102. Neuveut, C., Scoggins, R.M., Camerini, D., Markham, R.B., Jeang, K. T., 2003. Requirement for the second coding exon of Tat in the optimal replication of macrophage-tropic HIV-1. J. Biomed. Sci. 10, 651-660.
103. Newman, D.K., Hamilton, C., Newman, P.J., 2001. Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Blood 97, 2351-2357. (Pubitemid 32291481)
104. Newman, P.J., Newman, D.K., 2003. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler. Thromb. Vasc. Biol. 23, 953-964.
105. Nourshargh, S., Hordijk, P.L., Sixt, M., 2010. Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat. Rev. Mol. Cell Biol. 11, 366-378.
106. Oh, S.K., Cruikshank, W.W., Raina, J., Blanchard, G.C., Adler, W.H., Walker, J., Kornfeld, H., 1992. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J. Acquir. Immune Defic. Syndr. 5, 251-256.
107. Ohtsuki, S., Terasaki, T., 2007. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm. Res. 24, 1745-1758.
108. Persidsky, Y., Ghorpade, A., Rasmussen, J., Limoges, J., Liu, X.J., Stins, M., Fiala, M., Way, D., Kim, K.S., Witte, M.H., Weinand, M., Carhart, L., Gendelman, H.E., 1999. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155, 1599-1611.
109. Phillipson, M., Heit, B., Colarusso, P., Liu, L., Ballantyne, C.M., Kubes, P., 2006. Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade. J. Exp. Med. 203, 2569-2575.
110. Plateel, M., Dehouck, M.P., Torpier, G., Cecchelli, R., Teissier, E., 1995. Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer. J. Neurochem. 65, 2138-2145.
111. Price, T.O., Ercal, N., Nakaoke, R., Banks, W.A., 2005. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res. 1045, 57-63. (Pubitemid 40725220)
112. Price, T.O., Uras, F., Banks, W.A., Ercal, N., 2006. A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells. Exp. Neurol. 201, 193-202.
113. Pu, H., Tian, J., Flora, G., Lee, Y.W., Nath, A., Hennig, B., Toborek, M., 2003. HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Mol. Cell Neurosci. 24, 224-237.
114. Pu, H., Tian, J., Andras, I.E., Hayashi, K., Flora, G., Hennig, B., Toborek, M., 2005. HIV-1 Tat protein-induced alterations of ZO-1 expression are mediated by redox-regulated ERK 1/2 activation. J. Cereb. Blood Flow Metab. 25, 1325-1335.
115. Pu, H., Hayashi, K., Andras, I.E., Eum, S.Y., Hennig, B., Toborek, M., 2007. Limited role of COX-2 in HIV Tat-induced alterations of tight junction protein expression and disruption of the blood-brain barrier. Brain Res. 1184, 333-344. (Pubitemid 350160577)
116. Pulliam, L., Gascon, R., Stubblebine, M., McGuire, D., McGrath, M.S., 1997. Unique monocyte subset in patients with AIDS dementia. Lancet. 349, 692-695. (Pubitemid 27107748)
117. Pulliam, L., Sun, B., Rempel, H., 2004. Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load. J. Neuroimmunol. 157, 93-98. (Pubitemid 39576642)
118. Raine, C.S., Cannella, B., Duijvestijn, A.M., Cross, A.H., 1990. Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab. Invest. 63, 476-489.
119. Ramirez, S.H., Potula, R., Fan, S., Eidem, T., Papugani, A., Reichenbach, N., Dykstra, H., Weksler, B.B., Romero, I.A., Couraud, P.O., Persidsky, Y., 2009. Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells. J. Cereb. Blood Flow Metab. 29, 1933-1945.
120. Ranki, A., Nyberg, M., Ovod, V., Haltia, M., Elovaara, I., Raininko, R., Haapasalo, H., Krohn, K., 1995. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9, 1001-1008.
121. Sabatier, J.M., Vives, E., Mabrouk, K., Benjouad, A., Rochat, H., Duval, A., Hue, B., Bahraoui, E., 1991. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virol. 65, 961-967.
122. Sacktor, N., McDermott, M.P., Marder, K., Schifitto, G., Selnes, O.A., McArthur, J.C., Stern, Y., Albert, S., Palumbo, D., Kieburtz, K., De Marcaida, J.A., Cohen, B., Epstein, L., 2002. HIV-associated cognitive impairment before and after the advent of combination therapy. J. Neurovirol. 8, 136-142. (Pubitemid 34520894)
123. Schenkel, A.R., Mamdouh, Z., Muller, W.A., 2004. Locomotion of monocytes on endothelium is a critical step during extravasation. Nat. Immunol. 5, 393-400.
124. Sharma, H.S., Muresanu, D., Sharma, A., Patnaik, R., 2009. Cocaine-induced breakdown of the blood-brain barrier and neurotoxicity. Int. Rev. Neurobiol. 88, 297-334.
125. Shiu, C., Barbier, E., Di Cello, F., Choi, H.J., Stins, M., 2007. HIV-1 gp120 as well as alcohol affect blood-brain barrier permeability and stress fiber formation: involvement of reactive oxygen species. Alcohol Clin. Exp. Res. 31, 130-137.
126. Smith, G., 2006. Aging Hearing: HIV over Fifty, Exploring the New Threat. Senate Committee on Aging, Washington, DC.
127. Smith, S.M., Pentlicky, S., Klase, Z., Singh, M., Neuveut, C., Lu, C.Y., Reitz Jr., M.S., Yarchoan, R., Marx, P.A., Jeang, K.T., 2003. An in vivo replication-important function in the second coding exon of Tat is constrained against mutation despite cytotoxic T lymphocyte selection. J. Biol. Chem. 278, 44816-44825.
128. Sobel, R.A., Mitchell, M.E., Fondren, G., 1990. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am. J. Pathol. 136, 1309-1316.
129. Stamatovic, S.M., Shakui, P., Keep, R.F., Moore, B.B., Kunkel, S.L., Van Rooijen, N., Andjelkovic, A.V., 2005. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J. Cereb. Blood Flow Metab. 25, 593-606.
130. Stamatovic, S.M., Keep, R.F., Andjelkovic, A.V., 2008. Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr. Neuropharmacol. 6, 179-192.
131. Steffen, B.J., Butcher, E.C., Engelhardt, B., 1994. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am. J. Pathol. 145, 189-201.
132. Steiner, O., Coisne, C., Engelhardt, B., Lyck, R., 2011. Comparison of immortalized bEnd5 and primary mouse brain microvascular endothelial cells as in vitro blood-brain barrier models for the study of T cell extravasation. J. Cereb. Blood Flow Metab. 31, 315-327.
133. Tayarani, I., Chaudiere, J., Lefauconnier, J.M., Bourre, J.M., 1987. Enzymatic protection against peroxidative damage in isolated brain capillaries. J. Neurochem. 48, 1399-1402.
134. Thieblemont, N., Weiss, L., Sadeghi, H.M., Estcourt, C., Haeffner-Cavaillon, N., 1995. CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur. J. Immunol. 25, 3418-3424.
135. Toneatto, S., Finco, O., van der Putten, H., Abrignani, S., Annunziata, P., 1999. Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice. AIDS 13, 2343-2348.
136. Ueno, M., Nakagawa, T., Wu, B., Onodera, M., Huang, C.L., Kusaka, T., Araki, N., Sakamoto, H., 2010. Transporters in the brain endothelial barrier. Curr. Med. Chem. 17, 1125-1138.
137. Valcour, V., Shikuma, C., Shiramizu, B., Watters, M., Poff, P., Selnes, O., Holck, P., Grove, J., Sacktor, N., 2004a. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 63, 822-827.
138. Valcour, V., Paul, R., 2006. HIV infection and dementia in older adults. Clin. Infect. Dis. 42, 1449-1454.
139. Valcour, V.G., Shikuma, C.M., Watters, M.R., Sacktor, N.C., 2004b.
140. Van Itallie, C.M., Fanning, A.S., Bridges, A., Anderson, J.M., 2009. ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. Mol. Biol. Cell. 20, 3930-3940.
141. Vives, E., Brodin, P., Lebleu, B., 1997. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017.
142. Wang, L., Lim, E.J., Toborek, M., Hennig, B., 2008. The role of fatty acids and caveolin-1 in tumor necrosis factor alpha-induced endothelial cell activation. Metabolism 57, 1328-1339.
143. Weichold, F.F., Zella, D., Barabitskaja, O., Maciejewski, J.P., Dunn, D.E., Sloand, E.M., Young, N.S., 1998. Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most-primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures. Blood 91, 907-915.
144. Williams, K., Schwartz, A., Corey, S., Orandle, M., Kennedy, W., Thompson, B., Alvarez, X., Brown, C., Gartner, S., Lackner, A., 2002. Proliferating cellular nuclear antigen expression as a marker of perivascular macrophages in simian immunodeficiency virus encephalitis. Am. J. Pathol. 161, 575-585.
145. Williams, K., Westmoreland, S., Greco, J., Ratai, E., Lentz, M., Kim, W.K., Fuller, R.A., Kim, J.P., Autissier, P., Sehgal, P.K., Schinazi, R.F., Bischofberger, N., Piatak, M., Lifson, J.D., Masliah, E., Gonzalez, R.G., 2005. Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J. Clin. Invest. 115, 2534-2545.
146. Williams, K.C., Corey, S., Westmoreland, S.V., Pauley, D., Knight, H., deBakker, C., Alvarez, X., Lackner, A.A., 2001. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J. Exp. Med. 193, 905-915.
147. Williams, K.C., Hickey, W.F., 2002. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu. Rev. Neurosci. 25, 537-562.
148. Wong, D., Dorovini-Zis, K., Vincent, S.R., 2004. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Exp. Neurol. 190, 446-455.
149. Xiao, H., Neuveut, C., Tiffany, H.L., Benkirane, M., Rich, E.A., Murphy, P.M., Jeang, K.T., 2000. Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc. Natl. Acad. Sci. USA 97, 11466-11471.
150. Yamamoto, M., Ramirez, S.H., Sato, S., Kiyota, T., Cerny, R.L., Kaibuchi, K., Persidsky, Y., Ikezu, T., 2008. Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. Am. J. Pathol. 172, 521-533.
151. Yao, H., Yang, Y., Kim, K.J., Bethel-Brown, C., Gong, N., Funa, K., Gendelman, H.E., Su, T.P., Wang, J.Q., Buch, S., 2010. Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration. Blood 115, 4951-4962.
152. Yao, H., Duan, M., Buch, S., 2011a. Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability. Blood 117, 2538-2547.
153. Yao, H., Kim, K., Duan, M., Hayashi, T., Guo, M., Morgello, S., Prat, A., Wang, J., Su, T.P., Buch, S., 2011b. Cocaine hijacks {sigma}1 receptor to initiate induction of activated leukocyte cell adhesion molecule: implication for increased monocyte adhesion and migration in the CNS. J. Neurosci. 31, 5942-5955.
154. Yong, V.W., Krekoski, C.A., Forsyth, P.A., Bell, R., Edwards, D.R., 1998. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21, 75-80.
155. Zhao, C., Ling, Z., Newman, M.B., Bhatia, A., Carvey, P.M., 2007. TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiol. Dis. 26, 36-46.
156. Zhong, Y., Smart, E.J., Weksler, B., Couraud, P.O., Hennig, B., Toborek, M., 2008. Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. J. Neurosci. 28, 7788-7796.